Core Viewpoint - The company,领航医药生物科技, has announced a placement agreement to issue up to 145 million shares at a price of HKD 0.415 per share, representing a discount of approximately 9.78% from the closing price on August 21, 2025 [1] Group 1: Placement Details - The placement is expected to involve at least six independent third-party subscribers [1] - The maximum number of shares to be placed represents about 6.34% of the enlarged issued share capital [1] - If all shares are fully placed, the total proceeds from the placement will be approximately HKD 60.175 million [1] Group 2: Financial Implications - After deducting related expenses estimated at HKD 1.35 million, the net proceeds from the placement are expected to be around HKD 58.825 million [1] - The company intends to use the net proceeds entirely for funding the development of its blockchain technology business [1]
领航医药生物科技(00399)拟折让约9.78%发行1.45亿股配售股份 净筹5882.5万港元